Despite numerous challenges that cropped up during the year, Sanofi's vaccine outfit grew revenues 8.3% in 2017 to €5.1 billion ($6.25 billion), chipping in growth as the company's pharma segment struggled.Original Article
Sanofi Pasteur posts 8.3% growth despite 2017 vaccine setbacks
